NCT01293630 - A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions

Advanced Solid Tumors

Interventions

DRUG

Ombrabulin (AVE8062)

"Pharmaceutical form:solution~Route of administration: intravenous"

DRUG

Paclitaxel

"Pharmaceutical form:solution~Route of administration: intravenous"

DRUG

Carboplatin

"Pharmaceutical form:solution~Route of administration: intravenous"

Trial Locations (2)

Investigational Site Number 392002, Akashi-Shi

Investigational Site Number 392001, Hidaka-Shi